Health Condition 1: J069- Acute upper respiratory infection,unspecified
Conditions
Interventions
None listed
Sponsors
DR MEGHA IRANTAPPA SOLSHE
Eligibility
Inclusion criteria
Inclusion criteria: Subjects between the age group of 6years to 10 years. Subjects with mild to moderate Adenoidal hypertrophy in children. Presence of any of the following signs and symptoms of nasal obstruction, snoring, mouth breathing awake, mouth breathing asleep, restless sleep or difficulty breathing while asleep, nasal congestion, chronic nasal discharge, sleep apnea and hyponasal voice for at least 2 months. Adenoidal hypertrophy assessed on lateral neck radiograph as an air column/soft palate ratio less than one. Subjects in whom parents are willing to sign the written consent form will be included.
Exclusion criteria
Exclusion criteria: Subjects with deviated nasal septum, chronic sinusitis, laryngitis, tympanic retraction etc. Subjects with cleft lip and cleft palate. Subjects with severe form of Adenoidal hypertrophy in children. Use of any nasal, inhaled or systemic corticosteroids within the past 6 months. Use of antibiotics or any nasal medications within 1 month of entering the study. History of apnea lasting more than 15 seconds.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Significant decrease in Adenoidal hypertrophy assessed based on X-ray-Nasopharynx (Lateral view of Neck) findings. Significant decrease in Total symptom score. Timepoint: 0-42-70 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Significant decrease in the frequency of intervening illnesses. Generation of in-depth analysed data on the different aspect of the disease. Timepoint: 1 year | — |
Countries
India
Contacts
Public ContactDR R A DIVYASRI
Sri Sri College of Ayurvedic Science and Research Hospital Bangalore.
Outcome results
None listed